Should Magnetic Resonance Angiography Be Used for Screening of Intracranial Aneurysm in Adults with Sickle Cell Disease?

MR angiography MR imaging intracranial aneurysm sickle cell disease

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
16 Dec 2022
Historique:
received: 24 11 2022
revised: 10 12 2022
accepted: 14 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

Magnetic resonance imaging (MRI) is used in patients with sickle cell disease (SCD) to detect silent cerebral infarcts. MR angiography (MRA) can identify arterial stenoses and intracranial aneurysms (ICANs) associated with SCD. In this study, we aimed to estimate the prevalence of ICANs in asymptomatic adult patients with SCD referred from the SCD clinic for routine screening by MRI/MRA using a 3T-MRI scanner. Findings were independently reviewed by two neuroradiologists. Between 2016 and 2020, 245 asymptomatic adults with SCD were stratified according to genotype (SS/S-β0thalassemia and SC/Sβ+). ICANs were found in 27 patients (11%; 0.95 CI: 8-16%). ICANs were more frequent in SS/S-β0thalassemia patients (20/118 or 17%; 0.95 CI: 11-25%) than in SC/βb+ patients (7/127 or 6%; 0.95 CI: 2-11%;

Identifiants

pubmed: 36556079
pii: jcm11247463
doi: 10.3390/jcm11247463
pmc: PMC9786262
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Blood. 2016 Apr 21;127(16):2038-40
pubmed: 26941400
Blood. 2004 Jul 15;104(2):336-9
pubmed: 15054044
Lancet Neurol. 2011 Jul;10(7):626-36
pubmed: 21641282
J Neurosci Rural Pract. 2016 Jan-Mar;7(1):83-6
pubmed: 26933351
Blood Adv. 2020 Apr 28;4(8):1554-1588
pubmed: 32298430
AJNR Am J Neuroradiol. 2010 May;31(5):912-8
pubmed: 20019107
Br J Radiol. 2014 Aug;87(1040):20130699
pubmed: 24847772
Stroke. 2015 Aug;46(8):2368-400
pubmed: 26089327
Front Neurol. 2019 Aug 13;10:871
pubmed: 31474929
Blood. 1998 Jan 1;91(1):288-94
pubmed: 9414296
N Engl J Med. 1998 Jul 2;339(1):5-11
pubmed: 9647873
Trials. 2011 Mar 04;12:64
pubmed: 21375745
JAMA Netw Open. 2021 May 3;4(5):e217039
pubmed: 33983401
Stroke. 2014 Jan;45(1):119-26
pubmed: 24326447
Int J Vasc Med. 2012;2012:792834
pubmed: 22292121
JAMA. 2010 May 12;303(18):1823-31
pubmed: 20460621
Stroke. 2016 Jul;47(7):1710-3
pubmed: 27301940
N Engl J Med. 2007 Nov 1;357(18):1821-8
pubmed: 17978290
J Neuroimaging. 2020 Nov;30(6):725-735
pubmed: 33463866
Stroke. 2022 Nov;53(11):e463-e466
pubmed: 36205141

Auteurs

Igor Gomes Padilha (IG)

Radiology Department, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H3T 1J4, Canada.

François Guilbert (F)

Radiology Department, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H3T 1J4, Canada.

Laurent Létourneau-Guillon (L)

Radiology Department, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H3T 1J4, Canada.

Stéphanie Forté (S)

Haematology/Oncology Department, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H3T 1J4, Canada.

Kristoff Nelson (K)

Radiology Department, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H3T 1J4, Canada.

Manon Bélair (M)

Radiology Department, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H3T 1J4, Canada.

Jean Raymond (J)

Radiology Department, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H3T 1J4, Canada.

Denis Soulières (D)

Haematology/Oncology Department, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H3T 1J4, Canada.

Classifications MeSH